CG Oncology Inc.
CGON | NASDAQ
$78.24
-$0.01 (-0.01%)
Sep 22, 2026, 10:35 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.16M | 1.08M | 2.32M | 1.67M | n/a | 52K | 456K | 43K | 111K | 529K | 1K | 9K | n/a | 194K | n/a |
Cost of Revenue | 3.93M | 2.96M | 2.91M | 1.58M | 31.33M | 27.47M | 26.8M | 19.62M | 18.47M | 4K | 4K | 11.74M | 4K | 7.84M | 4K |
Gross Profit | -2.77M | -1.88M | -592K | 89K | -31.33M | -27.42M | -26.34M | -19.58M | -18.36M | 525K | -3K | -11.73M | -4K | -7.65M | -4K |
Operating Income | -86.4M | -66.39M | -48.7M | -51.13M | -48.74M | -42.2M | -38.05M | -28.3M | -25.85M | -22.47M | -18.93M | -14.04M | -12.33M | -9.72M | -9.32M |
Interest Income | 7.33M | 6.29M | 22.49M | 7.42M | 7.32M | 7.75M | 6.25M | 7.89M | 6.94M | 5.55M | 2.82M | 2.28M | 771K | 1.05M | 910K |
Pretax Income | -79.06M | -60.2M | -41.31M | -43.81M | -41.43M | -34.45M | -31.8M | -20.41M | -18.9M | -16.93M | -16.12M | -11.77M | -11.61M | -8.67M | -8.39M |
Net Income | -79.06M | -60.2M | -41.31M | -43.81M | -41.43M | -34.45M | -31.8M | -20.41M | -18.9M | -16.93M | -16.12M | -11.77M | -11.61M | -8.67M | -8.39M |
Selling & General & Admin | 28.98M | 20.78M | 17.99M | 23.33M | 17.41M | 14.79M | 11.71M | 8.72M | 7.49M | 5.78M | 3.01M | 2.32M | 2.49M | 2.07M | 1.65M |
Research & Development | 54.66M | 43.73M | 29.96M | 27.88M | 31.33M | 27.47M | 26.8M | 19.62M | 18.47M | 17.21M | 15.92M | 11.74M | 9.83M | 7.84M | 7.66M |
Other Expenses | n/a | n/a | 155K | n/a | -31.33M | -27.47M | -26.8M | -19.62M | -18.47M | n/a | n/a | -11.74M | -58K | -7.84M | 13K |
Operating Expenses | 83.63M | 64.51M | 48.11M | 51.22M | 17.41M | 14.79M | 11.71M | 8.72M | 7.49M | 22.99M | 18.93M | 2.32M | 12.32M | 2.07M | 9.31M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4K | -4K | n/a | -4K | n/a | -4K |
Cost & Expenses | 87.56M | 67.47M | 51.02M | 52.8M | 48.74M | 42.26M | 38.51M | 28.34M | 25.96M | 23M | 18.93M | 14.05M | 12.33M | 9.92M | 9.32M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 88.2M | 84.52M | 77.3M | 76.73M | 76.23M | 76.19M | 64.82M | 67.14M | 66.65M | 66.64M | 66.64M | 66.64M | 66.64M | 66.64M | 66.64M |
Shares Outstanding (Diluted) | 88.2M | 84.52M | 77.3M | 76.73M | 76.23M | 76.19M | 64.82M | 67.14M | 66.65M | 66.64M | 66.64M | 66.64M | 66.64M | 66.64M | 66.64M |
EPS (Basic) | -0.90 | -0.71 | -0.52 | -0.57 | -0.54 | -0.45 | -0.49 | -0.30 | -0.28 | -0.25 | -0.33 | -0.28 | -0.17 | -0.13 | -0.13 |
EPS (Diluted) | -0.90 | -0.71 | -0.52 | -0.57 | -0.54 | -0.45 | -0.49 | -0.30 | -0.28 | -0.22 | -0.33 | -0.28 | -0.17 | -0.13 | -0.13 |
EBITDA | -79.06M | -59.36M | -40.46M | -43.39M | -41.27M | -34.43M | -31.8M | -20.38M | -18.9M | -16.93M | -16.11M | -11.76M | -11.61M | -8.66M | -9.51M |
EBIT | -79.06M | -60.2M | -41.31M | -43.81M | -41.43M | -34.45M | -31.8M | -20.41M | -18.9M | -16.93M | -16.12M | -11.77M | -11.61M | -8.67M | -9.51M |
Depreciation & Amortization | n/a | 841K | 849K | 416K | 156K | 24K | n/a | 21K | 7K | 4K | 4K | 4.33K | 4K | 4K | 4K |
Add to Watchlist
Select watchlists to add or remove CGON